beta-Adrenergic Blocker

This page covers all beta-Adrenergic Blocker drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-1 adrenergic receptor, Beta-2 adrenergic receptor.

Targets

Beta-1 adrenergic receptor · Beta-2 adrenergic receptor

Marketed (8)

• Sectral · Promius Pharma · Neuroscience
• Betagan · AbbVie · Cardiovascular
• Brevibloc In Plastic Container · Pfizer · Cardiovascular
  Brevibloc works by blocking the beta-1 adrenergic receptor, which reduces the heart's response to stress and increases heart rate.
• Zebeta · Teva · Cardiovascular
• Ocupress · Cardiovascular
• Betoptic · Novartis · Cardiovascular
  Betaxolol works by blocking the beta-1 adrenergic receptor in the heart and eyes, reducing heart rate and pressure, and decreasing intraocular pressure.
• Optipranolol · Bausch Health · Cardiovascular
• Normodyne · Merck & Co. · Cardiovascular

Patent intelligence

• beta adrenergic blocker patent landscape — aggregated cliff calendar, attackable patents, originator estates